The effects of glycogen synthase kinase-3beta in serotonin neurons.
Glycogen synthase kinase-3 (GSK3) is a constitutively active protein kinase in brain. Increasing evidence has shown that GSK3 acts as a modulator in the serotonin neurotransmission system, including direct interaction with serotonin 1B (5-HT1B) receptors in a highly selective manner and prominent mo...
Main Authors: | Wenjun Zhou, Ligong Chen, Jodi Paul, Sufen Yang, Fuzeng Li, Karen Sampson, Jim R Woodgett, Jean Martin Beaulieu, Karen L Gamble, Xiaohua Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3422264?pdf=render |
Similar Items
-
Glycogen Synthase Kinase-3 is an intermediate modulator of serotonin neurotransmission
by: Xiaohua eLi, et al.
Published: (2011-10-01) -
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.
by: Brownlees, J, et al.
Published: (1997) -
The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
by: Honglu Yu, et al.
Published: (2023-09-01) -
Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.
by: Katsuya Tanabe, et al.
Published: (2008-02-01) -
Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity
by: Dipashree Chatterjee, et al.
Published: (2022-11-01)